A phase 3 trial of a higher-dose CagriSema formulation at 2.4/7.2 mg is planned for initiation in the second half of 2026, and the REDEFINE 11 trial, exploring CagriSemas full weight-loss potential, is expected to report data in the first half of 2027
It can also help to detoxify your liver, support your immune system and skin health
Conservative maintenance may use 1mg
Seven vendors carrying 19 distinct SKUs gives strong supply-side diversity, and the daily wicks are tight relative to retatrutide
Ideal for athletes and busy professionals, this infusion delivers essential nutrients directly into your bloodstream for imme Book Now Strengthen your immune system with our Immunity
This formulation builds upon the RT0 base system and introduces GHK-Cu as an active research component, allowing comparative analysis between non-active and peptide-infused matrices